Research graph
References from Comorbidity and geriatric assessment for older patients with hematologic malignancies: A review of the evidence. Local targets link to admitted publications; unresolved targets remain external evidence.
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
10.1016/j.critrevonc.2005.06.003 · 2005 · External reference
Unresolved reference
External reference
Cancer screening in elderly patients: a framework for individualized decision making
10.1001/jama.285.21.2750 · 2001 · External reference
Management of cancer in the older person: a practical approach
10.1634/theoncologist.5-3-224 · 2000 · External reference
Basic Assessment of the Older Cancer Patient
10.1007/s11864-011-0161-5 · 2011 · External reference
A specialized home care intervention improves survival among older post-surgical cancer patients
10.1111/j.1532-5415.2000.tb03886.x · 2000 · External reference
Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer: ELCAPA Study
10.1200/jco.2010.31.0664 · 2011 · External reference
A comprehensive geriatric intervention detects multiple problems in older breast cancer patients
10.1016/s1040-8428(03)00099-4 · 2004 · External reference
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study
10.1016/j.critrevonc.2007.11.001 · 2008 · External reference
The role of comprehensive geriatric assessement (CGA) in the management of stage 3 hepatocellular carcinoma in the elderly
2006 · External reference
Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study
10.1093/annonc/mdi368 · 2005 · External reference
Predicting falls in older patients using components of a comprehensive geriatric assessment
10.1188/08.cjon.941-949 · 2008 · External reference
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
10.1016/0021-9681(87)90171-8 · 1987 · External reference
Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale
10.1016/0165-1781(92)90005-n · 1992 · External reference
Measuring comorbidity in older cancer patients
10.1016/s0959-8049(99)00319-6 · 2000 · External reference
Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients
10.1007/s00432-007-0233-x · 2007 · External reference
Effect of comorbidity and age on survival in 73 patients with de novo acute leukemia
1995 · External reference
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
10.1002/cncr.22537 · 2007 · External reference
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
10.1182/blood-2005-05-2004 · 2005 · External reference
Treating octogenarian and nonagenarian acute myeloid leukemia patients—predictive prognostic models
10.1002/cncr.24285 · 2009 · External reference
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group
10.1093/annonc/mdp258 · 2010 · External reference
Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma
10.1007/s00432-010-0933-5 · 2011 · External reference
A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy
10.1002/cncr.24490 · 2009 · External reference
Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia
10.1080/10428190701724785 · 2008 · External reference
Assessment of outcome over a 10-year period of patients admitted to a multidisciplinary adult intensive care unit with haematological and solid tumours
10.1177/0310057x0503300105 · 2005 · External reference
Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States)
10.1007/s10552-005-0502-4 · 2006 · External reference
Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma
10.1002/cncr.11827 · 2003 · External reference
Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapy
10.1111/j.1532-5415.2010.03081.x · 2010 · External reference
Hyperglycemia During Chemotherapy for Hematologic and Solid Tumors Is Correlated With Increased Toxicity
10.1097/coc.0b013e3181e1d0c0 · 2011 · External reference
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients
10.1111/j.1365-2141.2007.06791.x · 2007 · External reference
Co-morbidity and functional deficits independently contribute to quality of life before chemotherapy in elderly cancer patients
10.1007/s00520-007-0228-9 · 2007 · External reference
Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry
10.1016/j.ejca.2005.01.010 · 2005 · External reference
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
10.1016/s0140-6736(10)61381-5 · 2010 · External reference
Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma
10.1016/j.bbmt.2008.05.002 · 2008 · External reference
Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma
10.1016/j.bbmt.2008.06.019 · 2008 · External reference
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation
10.1016/j.bbmt.2006.05.015 · 2006 · External reference
Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation
10.1016/j.bbmt.2008.11.023 · 2009 · External reference
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
10.1038/leu.2009.1 · 2009 · External reference
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
10.1182/blood-2008-07-172007 · 2009 · External reference
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group
10.1200/jco.1989.7.9.1268 · 1989 · External reference
10.1016/j.jgo.2011.02.002 · 2011 · Admitted local publication
A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project
10.1056/nejm199309303291402 · 1993 · External reference
Impairment in functional status and survival in patients with acute myeloid leukaemia
10.1007/s00432-006-0115-7 · 2006 · External reference
A critical review of the prognostic value of the nutritional status at diagnosis in the outcome of therapy of children with acute lymphoblastic leukemia
2003 · External reference
Patterns of care and survival in cancer patients with cognitive impairment
10.1016/j.critrevonc.2009.07.002 · 2010 · External reference
10.1016/j.jgo.2010.08.006 · 2011 · Admitted local publication
Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas
10.1093/annonc/mdi243 · 2005 · External reference
Management of breast cancer in the older woman
10.1177/107327480100800507 · 2001 · External reference
Comprehensive geriatric assessment-adapted chemotherapy in elderly patients (>70 years) with diffuse large cell B cell non-Hodgkin's lymphoma (DLCBL): final results and long term follow-up
10.1182/blood.v114.22.2684.2684 · 2009 · External reference
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
10.1200/jco.2011.34.7625 · 2011 · External reference
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
10.1002/cncr.26646 · 2011 · External reference
MAX2—a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials
10.1016/j.ejca.2004.01.028 · 2004 · External reference
A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin's lymphoma
10.3109/10428190009089435 · 2000 · External reference
Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia
10.1200/jco.1996.14.2.636 · 1996 · External reference
CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer
10.1002/cncr.20688 · 2004 · External reference
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
10.1038/sj.bjc.6600724 · 2003 · External reference
Can first cycle CBCs predict older patients at very low risk of neutropenia during further chemotherapy?
10.1016/j.critrevonc.2010.07.001 · 2011 · External reference
